Specifically, we found that the expression of SOST, an osteocyte-specific negative regulator of bone remodeling [40], was significantly reduced in the ColI(2.3)+/Rs1+ cochleae and correlated to the severity of graded FD lesions. This evidence concerns the gene SOST and Fabry disease.